BCL2L11 and ovarian carcinoma: In this study, we explicate the molecular mechanism of ATO in ovarian cancer cells and provide the first evidence that BIM-mediated AKT dephosphorylation is an important factor for ATO-induced apoptosis in cisplatin-sensitive and -resistant ovarian cancer cells.